SAFETY EVALUATION OF A LYOPHILIZED PLATELET DERIVED HEMOSTATIC PRODUCT

BACKGROUND: Hemorrhage causes significant morbidity and mortality in persons under 65. A lyophilized platelet-derived hemostatic agent (Thrombosomes) demonstrated hemostatic efficacy in animal models. We report the results of the first safety trial of autologous Thrombosomes given to normal subjects...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transfusion
Main Authors: Barroso, Jeffrey, Osborne, Barbara, Teramura, Gayle, Pellham, Esther, Fitzpatrick, Michael, Biehl, Ruth, Yu, Anna, Pehta, Joan, Slichter, Sherrill J.
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6301028/
https://ncbi.nlm.nih.gov/pubmed/30450601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.14972
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki